Catja Freiburghaus

Catja Freiburghaus

Company: Hansa Biopharma

Job title: Senior Scientist, Clinical Development Lead Gene Therapy


Evaluating the Risks & Benefits of Immunosuppression in Patients Prior to Gene Therapy Treatment 9:00 am

Tackling pre-existing immunity by utilizing enzymes to cleave IgGs in the blood that exist for the capsid Understanding the optimal time within the treatment phase to dose withb Immunosuppressants Exploring the ability to redose patients after immunosuppression treatmentsRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.